Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Validation of the French Version of the QASCI in Caregivers of Patients With COPD

Validation of the French Version of the Informal Caregiver Burden Assessment Questionnaire (QASCI) in Caregivers of Patients With COPD (VALQASCI)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study aims to validate the French version of the QASCI questionnaire, initially written and validated in Portuguese language by Hipolito et al., to assess caregiving burden in chronic obstructive pulmonary disease (COPD). The realization of this validation is significant on several levels. First, since COPD is a systemic condition, it affects not only the lungs but also many other organs and systems in the body. It leads to various complications that go beyond respiratory symptoms, creating major challenges not only physically but also in terms of participation and involvement for patients and their caregivers. The lack of validated tools in French to specifically assess the quality of life of caregivers in this context represents a gap that this study seeks to fill. This study is also justified by the fact that, although the QASCI has been validated in other languages and contexts, it is essential to linguistically and culturally adapt this tool for the French-speaking population. Validation in French is crucial to ensure the fidelity of the results obtained and the validity of the conclusions drawn from this instrument for caregivers of patients with COPD in France. In summary, this study addresses a specific need by contributing to the prevention of pathologies among caregivers. It enhances early detection and support for caregivers of patients with COPD while paving the way for future research on this often-overlooked population.

Who May Be Eligible (Plain English)

Who May Qualify: - Being a caregiver of a relative with COPD (according to the GOLD criteria). - Being 18 years old or older. - The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month). - Being a family member of the patient or living with the patient. - Being able to complete the French questionnaires. - Non-opposition statement provided. NON-INCLUSION CRITERIA - Person under judicial protection (guardianship, curatorship, etc.) - Refusal to participate - The patient under the caregiver's care has experienced an exacerbation in the previous month - The caregiver reports that the patient has cognitive impairments. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Being a caregiver of a relative with COPD (according to the GOLD criteria). * Being 18 years old or older. * The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month). * Being a family member of the patient or living with the patient. * Being able to complete the French questionnaires. * Non-opposition statement provided. NON-INCLUSION CRITERIA * Person under judicial protection (guardianship, curatorship, etc.) * Refusal to participate * The patient under the caregiver's care has experienced an exacerbation in the previous month * The caregiver reports that the patient has cognitive impairments.

Treatments Being Tested

OTHER

questionnaire

Caregivers must reply to the French version of the QASCI questionnaire, the ZBI (Zarit Burden Interview) questionnaire, HADS (Hospital Anxiety and Depression Scale), and WHOQOL-Bref (World Health Organization Quality of Life Instrument - Short Form). After 15 days, they wil reply to the French version of the QASCI questionnaire (to asse the reliability).

Locations (2)

Chu Brest
Brest, France
Centre hospitalier de Morlaix
Morlaix, France